Novo Nordisk A/S - Share repurchase programme
- 34
Bagsværd, Denmark, 21 August 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), also referred to as the Safe Harbour rules. This programme is part of the overall share repurchase programme of up to DKK 16 billion to be executed during a 12-month period beginning 2 February 2017.
Under the programme initiated 9 August 2017, Novo Nordisk will repurchase B shares for an amount up to DKK 3.9 billion in the period from 9 August 2017 to 30 October 2017.
Further information
| Media: | ||
| Anne Margrethe Hauge | +45 4442 3450 | [email protected] |
| Ken Inchausti (US) | +1 609 786 8316 | [email protected] |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | [email protected] |
| Hanna Ögren | +45 3079 8519 | [email protected] |
| Anders Mikkelsen | +45 3079 4461 | [email protected] |
| Christina Jensen | +45 3079 3009 | [email protected] |
| Kasper Veje (US) | +1 609 235 8567 | [email protected] |
Company announcement No 66/2017
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
GlobeNewswire Europe, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
